Hikma injects new life into annual profit, remains optimistic about 2015
11th Mar 2015 08:16
Strong performances in Hikma Pharmaceuticals' injectable drug business drove the company's annual pre-tax higher by over 20%, though a warning about the impact of the US dollar on 2015 revenues was perhaps behind an initial fall in the shares. The Jordanian drugmaker reported a 21% year-on-year incr
Read moreHika Pharma promoted to FTSE 100 but Tullow Oil gets kicked out
5th Mar 2015 15:01
Hika Pharmaceuticals and Tullow Oil are switching places at start of the second quarter of this year as the FTSE Group reshuffles components across its leading London benchmarks. In its quarterly review, the FTSE Group have outlined which companies have been promoted or demoted from its indices. The
Read moreSector movers: GSK leads defensive pharma stocks higher
4th Feb 2015 14:35
A massive cash return by Glaxosmithkline gave the wider sector a lift on Wednesday, with defensive healthcare and pharmaceutical stocks also benefiting from a reduction in risk appetite as UK markets pulled back from a five-month high. Sales, profits and earnings slumped during the fourth quarter of
Read moreHikma Pharmaceuticals hiked by court colchicine ruling
12th Jan 2015 08:08
A US court has given Hikma Pharmaceuticals permission to distribute its colchicine gout treatment, turning down rival Takeda Pharmaceuticals in its appeal for an injunction against the distribution of the drugs. The injunction, which was granted to Takeda on 9 October 2014, has been vacated followin
Read moreFTSE 250 movers: Energy sector struggles as oil price continues to slide
5th Jan 2015 14:04
Oil producers such as Afren and Premier Oil, and energy services firms Wood Group, Hunting and Petrofac, were all falling sharply on Monday as the price of oil continued to sink. Brent crude dropped below $55 a barrel (bbl) for the first time since May 2009. Afren was also continuing to decline afte
Read moreLondon midday: Resource stocks drag FTSE 100 into the red
5th Jan 2015 11:36
UK stocks were trading firmly in the red by Monday lunchtime despite a positive start, with shares in the oil and mining sectors providing a drag. London's FTSE 100 was down 0.9% at 6,489 by midday, dropping sharply after reaching a high of 6,576.74 early on. This week will be the first full tradin
Read moreHikma soars after bullish recommendation from brokers
5th Jan 2015 10:14
Hikma Pharmaceuticals shares edged closer to an all-time high on Monday, in the wake of bullish recommendation from two brokers. The stock, which rose 66.8% in 2014, was among Europe's best performing small-cap after JP Morgan lifted its price target on Hikma shares by 18.4% and maintained an 'overw
Read moreSector movers: Defensive pharma stocks fall as Santa Rally continues
23rd Dec 2014 16:18
Pharmaceutical and healthcare stocks were leading the fallers on Tuesday as investors dumped defensive assets amid a continued pre-Christmas rally. UK stocks have risen for six straight days as markets rebounded strongly following a recent sell-off. While more cyclical sectors such as construction
Read moreThursday broker round-up
4th Dec 2014 08:46
Aberdeen: Charles Stanley downgrades to 'hold'. Afren: Canaccord reduces target price from 115p to 65p, while staying with its 'speculative buy' recommendation. Amino Technologies: Northland moves target price from 120p to 130p and retains a 'buy' recommendation. Belgravium Technologies: WH Irelan
Read moreFTSE 250 movers: Supergroup rises as Numis reaffirms rating
6th Nov 2014 15:45
Supergroup rose after Numis Securities reaffirmed its 'hold' rating on the stock, with a target price of 1,100p which would suggest a potential upside of 41.21% from the stock's previous close. Since 31 October, three other analysts firms, Berenberg, Investec and Cantor Fitzgerald Europe, reiterated
Read moreLondon midday: UK stocks hit by Ebola worries, travel stocks fall
24th Oct 2014 11:33
UK stocks fell on Friday morning after the FTSE 100 hit its highest level in two weeks the previous session, with investors treading cautiously after another reported case of Ebola in the States. The Footsie was down 0.3% at 6,397 by midday, but had pared losses after hitting a low of 6,374.24 early
Read moreLondon open: Ebola fears hit UK stocks after NY doctor tests positive for virus
24th Oct 2014 08:35
UK stocks experienced some selling pressure on Friday morning after rising to their highest in two weeks, as renewed concerns about the spread of Ebola weighed on market sentiment. The FTSE 100 was down 0.6% at 6,380 in early deals, after having closed Thursday's session at 6,419.15, its highest fin
Read moreHikma Pharmaceuticals receives warning letter from FDA
24th Oct 2014 07:38
Pharmaceuticals group Hikma received a warning letter from the US Food and Drug Administration overnight relating to its manufacturing facility in Portugal. The agency raised issues related to investigations and environmental monitoring at the facility. The warning is not expected to impact the manu
Read moreLondon pre-open: FTSE to open lower ahead of German data, UK GDP
24th Oct 2014 07:31
Reports of a new case of Ebola in the States, together with upcoming EU bank stress test results and German consumer confidence figures, are all set to provide a drag on UK markets at Friday's opening bell. City sources predict the FTSE 100 will open around 20 points lower than Thursday's close of 6
Read moreHikma non-exec sells 7,000 shares
10th Oct 2014 16:25
Ronald Goode, a non-executive director at Hikma Pharmaceuticals, on Thursday traded in £129,640-worth of shares in the group. The move proved a fortunate one for Goode, as the company's share price fell more than 3% in Friday's trading after the group learned that distribution of its colchicine 0.6
Read more